Clinical Trials

229 enrolled

Colorectal Neoplasms

NCT07617246 2026-06-01

The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT07618910 2026-06-01

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

33 enrolled

Esophageal Squamous Cell Carcinoma

NCT05099848 2026-05-22

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

21 enrolled

Carcinoma, Hepatocellular

NCT07564466 2026-05-11

A Study of SKB571 in Participants With Gastrointestinal Tumors

Digestive System Neoplasms

NCT07450976 2026-03-31

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

151 enrolled

Biliary Tract Neoplasms

NCT07398339 2026-02-09

DVDMS

Biliary Tract Neoplasms

NCT07110571 2026-01-09

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

200 enrolled

Stomach Neoplasms

NCT04727307 2025-09-30

AB-LATE02

202 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT06526338 2025-09-30

Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone

126 enrolled

Carcinoma, Hepatocellular

NCT06947291 2025-09-08

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

GastrointestinalOther solid neoplasm

350 enrolled

Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

NCT07151872 2025-09-03

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

CLDN18.2-positive Advanced Biliary Tract Cancer

NCT05229588 2025-08-15

Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations

8 enrolled

Gastrointestinal Malignancies

NCT06356688 2025-08-08

A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Phase 2 Active not recruiting

Esophageal Squamous Cell Carcinoma

NCT03350126 2025-07-23

NIPICOL

57 enrolled

Colonic Neoplasms, Microsatellite Instability

NCT06199895 2025-06-03

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

BreastGastrointestinalThoracic

25 enrolled

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT05870800 2025-05-25

NICER

28 enrolled

Colonic Neoplasms

NCT04863430 2025-02-21

Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach

Phase 2 Withdrawn

Stomach Neoplasms

NCT06760520 2025-01-08

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

40 enrolled

Locally Advanced Rectal Cancer

NCT06558227 2024-12-16

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

90 enrolled

Carcinoma, Hepatocellular

NCT06599775 2024-09-19

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

42 enrolled

Resectable Esophageal Squamous Cell Carcinoma

NCT06508229 2024-07-18

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

65 enrolled

Esophageal Squamous Cell Carcinoma

NCT06415669 2024-05-29

A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma

Stomach Neoplasms

NCT04329429 2023-12-20

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

57 enrolled

Biliary Tract Neoplasms

NCT05996484 2023-08-21

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma

25 enrolled

Esophageal Neoplasms

NCT04454905 2023-04-19

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

50 enrolled

Cholangiocarcinoma

NCT05616494 2023-03-22

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

53 enrolled

Pancreatic Neoplasms

NCT05705635 2023-01-31

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

100 enrolled

Gastric Adenocarcinoma

NCT03556345 2022-01-13

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2

127 enrolled

Stomach Neoplasms

NCT04642664 2021-06-03

ACABC

22 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT04225364 2021-02-02

Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma

56 enrolled

Esophageal Squamous Cell Carcinoma

NCT04581876 2020-10-09

The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer

Pancreatic Neoplasms

NCT04345783 2020-04-14

Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer

Stomach Neoplasms

NCT03192735 2020-02-05

Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer

50 enrolled

Apatinib Combined

NCT02301481 2019-10-16

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

71 enrolled

Stomach Neoplasms

NCT01967875 2019-05-30

A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer

Phase 2 Terminated

27 enrolled

CNSGastrointestinalGenitourinary

Stomach Neoplasms

NCT02584400 2019-03-08

HX4 SD

Phase 2 Terminated

1 enrolled

Hypoxia, Brain Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Rectal Neoplasms

NCT01386242 2016-01-05

Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

108 enrolled